Skip to content

Clinical trials

Hemorrhage trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Country / region: Japan Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20095
20101
20112
20141
20151
20162
20171
20181
20203
20211
20222
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting6
Active, not recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc4
Pfizer4
Boehringer Ingelheim3
Celgene3
Regeneron Pharmaceuticals2
Takeda2
Abbott Medical Devices1
Aesculap AG1
Alexion Pharmaceuticals, Inc.1
Boston Scientific Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage27
Venous Thromboembolism7
Atrial Fibrillation4
Stroke4
Arrhythmias, Cardiac3
Heart Failure3
Hemophilia A3
Hemophilia B3
Hypersensitivity3
Infections3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.